MedPath

Individualized Plan for Improving Adherence to Portable Oxygen Therapy in Patients With Respiratory Pathology

Not Applicable
Completed
Conditions
COPD
ILD
Dyspnea
Registration Number
NCT04691336
Lead Sponsor
Air Liquide Healthcare Spain
Brief Summary

Pilot study with patients with prescription of portable oxygen therapy, to test the impact on adherence of a patient-centered empowerment program, with contents on the nature of the respiratory pathology, the symptom of dyspnea, the benefits of the therapy, adjustment expectations and beliefs, as well as health habits.

Detailed Description

All patients were summoned to the care center, being evaluated individually by a nurse, and based on the results, a care plan adapted to the specific needs and objectives was initiated. This care plan involved monitoring using different channels (face-to-face, telephone), with the main objective of monitoring the evolution of compliance, adherence and improving the quality of life of patients. The interventions that were carried out were educational and formative (using counseling communication skills), and technological (using monitoring tools in specific cases). The empowerment program was an educational session in which the nurse discussed content about dyspnea, the benefits of therapy, etc.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Adult patients (over 18 years old) with prescription of portable oxygen therapy by the Pneumology Service of the Sant Joan de Dèu Hospital in Manresa.
Exclusion Criteria
  • Psychophysical inability to carry out questionnaires or refusal to answer them.
  • Severe displacement problems.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Adherence - ChangesDay 1 and Day 90

Number of hours of use of oxygen concentrator / day

Emotional State - ChangesDay 1 and Day 90

Mood, measured with a 3 level likert item . Minimum score: 0, Maximum score: 2. A high score implies a better outcome.

ActivitiesDay 1 and Day 90

Level of activity. measured with a 3 level likert item . Minimum score: 0, Maximum score: 2. A high score implies a better outcome.

Dyspnea - ChangesDay 1 and Day 90

Level of dyspnea, measured with the mMRC scale. Minimum score: 0, Maximum score: 4. A high score implies a worse outcome.

Quality of Life - ChangesDay 1 and Day 90

General well-being state, measured with a visual analog scale. Minimum score: 0, Maximum score: 10. A high score implies a better outcome.

Social RelationsDay 1 and Day 90

Level of social activity. measured with a 3 level likert item . Minimum score: 0, Maximum score: 2. A high score implies a better outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

David Rudilla

🇪🇸

Madrid, Spain

David Rudilla
🇪🇸Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.